Neue Rheinischezeitung - News from Cologne, North Rhine-Westphalia, Germany and the world

Köln -
Auger-Aliassime retires injured from Melbourne first round
China says economy grew 5% last year, among slowest in decades
China says economy grew 5% last year, among slowest in decades

China's economy expanded five percent in 2025, Beijing said Monday, one of its slowest rates of growth in decades as it struggles with persistently low consumer spending and a debt crisis in its property sector.

January 19, 2026

RECENT NEWS

Young star Zheng may have to give back Australian Open prize money
Young star Zheng may have to give back Australian Open prize money

American rising star Michael Zheng faces the prospect of giving back his Australian Open prize money as a college student, but is hoping a concession can be made.

January 19, 2026

Gauff overcomes wobble in winning start to Melbourne title bid
Gauff overcomes wobble in winning start to Melbourne title bid

Third seed Coco Gauff overcame some early serving wobbles to begin her Australian Open title bid with a straight-sets win on Monday.

January 19, 2026

Harry set for final courtroom battle against UK media
Harry set for final courtroom battle against UK media

Prince Harry is to return to London this week for the trial into his claims that a UK newspaper group unlawfully gathered information, in the royal's last case in his long-running crusade against the media.

January 19, 2026

RECENT NEWS

Morocco fans stunned, disappointed as Senegal win Africa title
Morocco fans stunned, disappointed as Senegal win Africa title

Moroccan fans walked out of the Prince Moulay Abdellah Stadium in the capital Rabat in utmost despair as Senegal stunned the hosts in Sunday's Africa Cup of Nations final in an extra-time thriller.

January 19, 2026

RECENT NEWS

BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF
BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF

VANCOUVER, BC / ACCESS Newswire / January 19, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has completed and received preliminary results from its comparative pharmacokinetics ("PK") large-mass animal study in pigs. The study measured how efficiently cladribine is absorbed into the bloodstream over time and compared BioNxt's proprietary orally dissolving film ("ODF") with the reference tablet formulation, evaluating the Company's swallow-free, sublingual ODF formulation for Multiple Sclerosis (MS).

January 19, 2026